Overview

Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.

Status:
Terminated

Trial end date:
2020-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to microscopically examine breast cancer cells of pre-menopausal and post-menopausal women before and after exposure to one of the two commonly used breast cancer drugs, tamoxifen or fulvestrant.

Phase:

Phase 1

Details

Lead Sponsor:

Icahn School of Medicine at Mount Sinai

Collaborator:

AstraZeneca

Treatments:

Estradiol
Fulvestrant
Tamoxifen